ALPINI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 139
AS - Asia 71
EU - Europa 71
SA - Sud America 2
Totale 283
Nazione #
US - Stati Uniti d'America 136
IT - Italia 47
SG - Singapore 45
CN - Cina 16
IE - Irlanda 5
SE - Svezia 5
ID - Indonesia 4
FI - Finlandia 3
IN - India 3
CA - Canada 2
CH - Svizzera 2
GB - Regno Unito 2
PT - Portogallo 2
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
JP - Giappone 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
PH - Filippine 1
TR - Turchia 1
Totale 283
Città #
Singapore 30
New York 22
Rome 19
Ashburn 7
Boardman 6
Indianapolis 6
Dublin 5
Turin 5
Boston 4
Fairfield 4
Yogyakarta 4
Lappeenranta 3
Stockholm 3
Adelfia 2
Atlanta 2
Austin 2
Cambridge 2
Council Bluffs 2
Houston 2
Lisbon 2
Milan 2
Paderno Dugnano 2
Pittsburgh 2
Revere 2
Rochester 2
Rockville 2
Saint-Sulpice 2
San Paolo di Civitate 2
Sapri 2
Seattle 2
Shanghai 2
Toronto 2
Woodbridge 2
Amsterdam 1
Andover 1
Bari 1
Bologna 1
Buenos Aires 1
Cingoli 1
Edinburgh 1
Fremont 1
Fuzhou 1
Hangzhou 1
Istanbul 1
Lawrence 1
Liberty 1
Millbury 1
North Bergen 1
Norwalk 1
Padova 1
Prague 1
Princeton 1
Pune 1
Redwood City 1
Salerno 1
Santa Clara 1
Sofia 1
São Paulo 1
Wandsworth 1
Wilmington 1
Yancheng 1
Totale 186
Nome #
Cholangiocarcinoma: novel therapeutic targets 37
Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis 36
p16 INK4A drives non-alcoholic fatty liver disease phenotypes in high fat diet fed mice via biliary e2f1/foxo1/igf-1 signaling 30
Knockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity 19
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis 19
Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury 18
Kupffer cells: inflammation pathways and cell-cell interactions in alcohol-associated liver disease 17
Mast cells in liver disease progression: an update on current studies and implications 15
FGF1 signaling modulates biliary injury and liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis 15
Molecular mechanisms linking risk factors to cholangiocarcinoma development 15
Downregulation of p16 decreases biliary damage and liver fibrosis in the Mdr2/ mouse model of primary sclerosing cholangitis 12
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes 12
Prolonged administration of melatonin ameliorates liver phenotypes in cholestatic murine model 12
The effects of taurocholic acid on biliary damage and liver fibrosis are mediated by calcitonin-gene-related peptide signaling 11
Mast cells promote nonalcoholic fatty liver disease phenotypes and microvesicular steatosis in mice fed a western diet 11
The functional roles of immune cells in primary liver cancer 10
Mast cells selectively target large cholangiocytes during biliary injury via H2HR-mediated cAMP/pERK1/2 signaling 9
Circadian rhythm and melatonin in liver carcinogenesis: updates on current findings 9
Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC) 8
Cyclic AMP signaling in biliary proliferation: a possible target for cholangiocarcinoma treatment? 8
Modulation of the tryptophan hydroxylase 1/monoamine oxidase-A/5-hydroxytryptamine/5-hydroxytryptamine receptor 2A/2B/2C axis regulates biliary proliferation and liver fibrosis during cholestasis 8
Amelioration of Ductular reaction by stem cell derived extracellular vesicles in MDR2 knockout mice via Lethal-7 microRNA 7
Possible application of melatonin treatment in human diseases of the biliary tract 7
Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes 7
Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2-/- mice 5
Inhibition of secretin/secretin receptor axis ameliorates NAFLD phenotypes 5
Gallstone and gallbladder disease: biliary tract and cholangiopathies 5
Totale 367
Categoria #
all - tutte 3.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 7 2 2
2020/20217 0 2 0 0 0 1 0 0 3 1 0 0
2021/202210 0 1 1 0 1 0 0 1 0 1 2 3
2022/2023112 2 3 0 1 1 4 1 1 3 38 18 40
2023/2024194 23 25 16 15 19 34 3 16 2 13 13 15
2024/202533 2 3 23 5 0 0 0 0 0 0 0 0
Totale 367